Background: To investigate the effect of IV liposomal quercetin (a known down-regulator of heat shock proteins) alone and with liposomal doxorubicin on tumor growth and end-point survival when combined with radiofrequency (RF) tumor ablation in a rat tumor model.
Methods: Solitary subcutaneous R3230 mammary adenocarcinoma tumors (1.3-1.